Reflex Syncope

3

Review clinical trials related to Reflex Syncope. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)

To characterize the impact of orthostatic hypotension (OH) and Vasovagal syncope on signals measured using a wearable Holter monitor in the clinic and ambulatory setting. To evaluate the relationship of signals measured from the Holter monitor with reported symptom severity of orthostatic intolerance per standard data collection, analysis, and questionnaires.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Boston Scientific CorporationUpdated: Jun 17, 2026Locations: 1
Eligibility criteria

Willing and capable to provide informed consent [+4]

Currently enrolled in another clinical trial that might interfere with data coll... [+8]

Status: Not yet recruiting

Implantable Loop Recorder and Cardioneuroblation

The study aims to determine which method of vagal ganglia ablation is most effective in preventing recurrences of reflex asystole syncope. Currently, some centers perform ablation only in the right atrium, others in both atria (biatrial). There are no comparative studies between the two procedures

Participants needed: 50
Trial details
Age: 18-18Biological sex: AllType: ObservationalSponsor: Istituto Auxologico ItalianoUpdated: Sep 9, 2025Locations: 1Duration: 12 Months
Eligibility criteria

Age 18 to 60 years [+3]

Intrinsic sinus dysfunction or atrioventricular node disease. [+4]

Status: Recruiting

Cardioinhibitory Reflex Syncope. Permanent Pacemaker Therapy or Cardioneuroablation?

Reflex syncope is the most common form of syncope. It can lead to injuries and affect quality of life. Nonpharmacological and medical therapies have limited effectiveness. In certain patients, cardiac pacing seem to be beneficial. More recently cardioneuroablation (CNA) has emerged as a novel therapy for reflex syncope. The investigators aim to determine whether CNA is more effective than cardiac pacing at reducing the rate of cardioinhibitory-type reflex syncope.

Participants needed: 90
Trial details
Age: 40+Biological sex: AllType: InterventionalSponsor: Institut d'Investigació Biomèdica de BellvitgeUpdated: Jan 25, 2024Locations: 10
Eligibility criteria

Aged more than 40 years. [+7]

Intrinsic sinus or atrioventricular nodal disease with a proven indication for p... [+4]